Pyrimethamine
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Pyrimethamine contains ▲NLT 98.0% and NMT 102.0%▲ (USP 1-May-2024) of pyrimethamine (C₁₂H₁₃ClN₄) calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: ▲197A or▲ (USP 1-May-2024) 197K
B. Identification Tests—General 〈191〉, Chemical Identification Tests, Chloride
Sample solution: Mix about 100 mg of Pyrimethamine with 500 mg of anhydrous sodium carbonate, and ignite the mixture. Cool, add 5 mL of hot water, heat for 5 min on a steam bath, filter, and neutralize the filtrate with nitric acid.
Acceptance criteria: Meets the requirements
C. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Change to read:
Procedure
Solution A: Add 1 mL of phosphoric acid to water and dilute with water to 1000 mL.
Mobile phase: Acetonitrile and Solution A (17:83)
Standard solution: 0.02 mg/mL of USP Pyrimethamine RS in Solution A
Sample solution: 0.02 mg/mL of Pyrimethamine in Solution A
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 210 nm
Column: 2.0-mm × 10-cm; 3-µm packing L11
Flow rate: 0.3 mL/min
Injection volume: 5 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 1.8
Relative standard deviation: NMT ▲0.73%▲ (USP 1-May-2024)
| Time (min) | Solution A (%) | Solution B (%) |
|---|---|---|
| 0 | 65 | 35 |
| 6 | 65 | 35 |
| 20 | 40 | 60 |
| 30 | 55 | 45 |
| 35 | 65 | 35 |
| 40 | 65 | 35 |
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of pyrimethamine (C₁₂H₁₃ClN₄) in the portion of Pyrimethamine taken:
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × 100
rᵤ = peak response of pyrimethamine from the Sample solution
rₛ = peak response of pyrimethamine from the Standard solution
Cₛ = concentration of USP Pyrimethamine RS in the Standard solution (mg/mL)
Cᵤ = concentration of Pyrimethamine in the Sample solution (mg/mL)
Acceptance criteria: ▲98.0%–102.0%▲ (USP 1-May-2024) on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
Delete the following:
▲Ordinary impurities 〈466〉▲ (USP 1-May-2024)
Add the following:
Organic Impurities
Solution A: 2.72 g/L of potassium phosphate monobasic in water. Adjust with 25% ammonium hydroxide to a pH of 8.0.
Solution B: Acetonitrile
Mobile phase: See Table 1.
Diluent: Solution A and Solution B (50:50)
Sensitivity solution: 0.0005 mg/mL of USP Pyrimethamine RS in Diluent
Standard solution: 0.001 mg/mL of USP Pyrimethamine RS in Diluent. Sonicate to dissolve.
Sample solution: 1 mg/mL of Pyrimethamine in Diluent. Sonicate to dissolve.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 210 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Column temperature: 30°
Flow rate: 1 mL/min
Injection volume: 10 µL
System suitability
Samples: Sensitivity solution and Standard solution
[Note—The relative retention times in Table 2 are provided as information that could aid in peak assignment.]
Table 2
| Name | Relative Retention Time |
|---|---|
| Chlorophenyl oxopentanenitrileᵃ | 0.56 |
| 3-Deschloro metoprineᵇ | 0.75 |
| Pyrimethamine | 1.0 |
| p-Chlorobenzyl nitrileᶜ | 1.4 |
| Chlorophenyl ketal analogᵈ | 2.1 |
ᵃ 2-(4-Chlorophenyl)-3-oxopentanenitrile.
ᵇ 5-(4-Chlorophenyl)-6-methylpyrimidine-2,4-diamine.
ᶜ 2-(4-Chlorophenyl)acetonitrile.
ᵈ 2-(4-Chlorophenyl)-2-(2-ethyl-1,3-dioxolan-2-yl)acetonitrile.
Suitability requirements
Relative standard deviation: NMT 5.0%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Pyrimethamine taken:
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × (1/F) × 100
rᵤ = peak response of each impurity from the Sample solution
rₛ = peak response of pyrimethamine from the Standard solution
Cₛ = concentration of USP Pyrimethamine RS in the Standard solution (mg/mL)
Cᵤ = concentration of Pyrimethamine in the Sample solution (mg/mL)
F = relative response factor (see Table 3)
Acceptance criteria: See Table 3. The reporting threshold is 0.05%.
Table 3
| Name | Relative Response Factor | Acceptance Criteria, NMT (%) |
|---|---|---|
| Chlorophenyl oxopentanenitrile | 0.44 | 0.10 |
| 3-Deschloro metoprine | 1.1 | 0.10 |
| p-Chlorobenzyl nitrile | 0.44 | 0.10 |
| Chlorophenyl ketal analog | 0.21 | 0.10 |
| Any unspecified impurity | 1.0 | 0.10 |
| Total impurities | — | 0.50 |
5 SPECIFIC TESTS
Delete the following:
▲Melting Range or Temperature 〈741〉▲ (USP 1-May-2024)
Loss on Drying 〈731〉
Analysis: Dry it at 105° for 4 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers.
USP Reference Standards 〈11〉
USP Pyrimethamine RS

